Atopic dermatitis


The recent addition of advanced therapies, monoclonal antibodies and Janus kinase (JAK) inhibitors is changing the management and improving long-term outcomes for people living with atopic dermatitis. This article looks in detail at treatments for atopic dermatitis and advice that pharmacists may offer patients. By Dr Jenny Gowan AM, PhD, Grad Dip Comm Pharm, FPS,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?